Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using entropy to detect sleep breathing problems in chronic lung disease

Official title: The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease

Run by University College, London · NCT07060079 · Data updated 2026-11-12

This project will test whether entropy measurements from simple overnight oxygen and pulse recordings can find sleep-disordered breathing in adults with chronic lung conditions such as COPD, asthma, bronchiectasis, and interstitial lung disease.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorUniversity College, London
Academic / other
Locations1 site (London)
StatusRecruiting
StartedApril 30, 2025
Main results expectedAugust 30, 2026
Study endsSeptember 30, 2026
Registry record updatedJuly 11, 2025
Trial IDNCT07060079 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age 18 and over) with chronic respiratory disease (COPD, asthma, bronchiectasis, or interstitial lung disease) who can give informed consent and are willing to sleep with portable monitoring devices are ideal candidates.

Probably not a fit

Children, people unable to use portable monitoring or give consent, and patients with contraindications to portable monitoring or who require full in-lab testing for complex sleep disorders are unlikely to benefit from this screening approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study applies nonlinear entropy analysis (for example, sample entropy) to physiological signals such as oxygen saturation and pulse rate recorded overnight with portable monitors. Researchers will compare entropy measures between adults with chronic respiratory diseases who do and do not have sleep-disordered breathing to identify characteristic differences. The approach aims to determine whether relatively simple finger pulse oximetry can provide useful screening information versus full cardiorespiratory testing. If successful, this method could clarify complex interactions between heart rate and oxygen signals during sleep in this patient group.

Why it matters

Potential benefit: If successful, this method could allow earlier or simpler detection of sleep-disordered breathing using low-burden overnight oximetry instead of full polysomnography for some patients.

How similar studies have gone: Entropy and other nonlinear metrics have shown promise in cardiovascular research and some sleep-oximetry screening work, but their application specifically to obstructive sleep apnoea in chronic respiratory disease is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All adult patients (≥ 18years) with chronic respiratory disease with/without SDB.
* patients who have had previously negative studies as a control group.
* Subject is able to read, understand, and sign the informed consent form.
* Willing to sleep with portable monitoring devices.

Exclusion Criteria:

* Patients who are under 18 years of age at the time of the index study.
* Contraindications to the use of portable monitoring.
* Inability to give informed consent to take part in the study.

Where it's running

  • Royal Free hospital
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Shuttle Walking Test to predict breathing problems after lung surgery

    This project will use a simple shuttle walking test before lung surgery to see if it predicts breathing problems and quality-of-life changes in people with chronic lung disease.

    Recruiting Seoul National University Bundang Hospital · Seongnam-si, Not Required For This Country · NCT07102589

  • Using the Lung Sliding Index to distinguish common lung diseases

    This project will test whether the Lung Sliding Index (LSI) measured by bedside ultrasound can tell apart various lung conditions in adults with lung disease and in healthy volunteers.

    Recruiting Assiut University · Asyut · NCT06983366

  • Using breath analysis to identify multiple lung diseases

    This study is testing if analyzing breath samples can help identify different lung diseases like lung cancer and COPD in a large group of 10,000 people.

    Recruiting ChromX Health · Guangzhou, Guangdong · NCT06528418

  • Community- or home-based exercise for adults with weakened heart or lungs

    This test will see if an eight-week, community- or home-based exercise program can improve heart and lung function in adults 18–85 with reduced cardiopulmonary fitness.

    Recruiting Guangdong Provincial People's Hospital · Guangzhou, Guangdong · NCT07154355

  • Bailing Capsules with Guben Kechuan Granules for stable bronchiectasis

    This trial will try whether adding Bailing Capsules plus Guben Kechuan Granules to standard Western treatment reduces acute exacerbations in adults with stable bronchiectasis.

    Recruiting Phase 4 Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang and 4 other locations · NCT07114120

  • Monitoring vital signs in patients using long-term oxygen therapy

    This study tests if using a wearable device to monitor vital signs can improve the quality of life for adults with COPD and interstitial lung disease who are on long-term oxygen therapy.

    Recruiting University of Sao Paulo General Hospital · São Paulo, São Paulo · NCT06882265

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.